Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01397292 · ClinicalTrials.gov registry record
Registry for Patients Undergoing Pulmonary Procedures
A clinical trial, sponsored by Virginia Commonwealth University.
- Terminated
- Registry status
- 220
- Enrollment target
NCT01397292: Clinical Trial study, sponsored by Virginia Commonwealth University.
NCT01397292 is a clinical trial that was terminated before completion, run by Virginia Commonwealth University. The registered enrollment target is 220 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01397292 was terminated before completion, sponsored by Virginia Commonwealth University.
- TERMINATED
- Registry status
- 220 participants
- Enrollment target
Study Summary
The purpose of this research study is to examine the safety, tolerability, and effectiveness of currently available pulmonary procedures when used to diagnose or treat different diseases. This study will collect information that may influence the outcome of the procedure and identify factors that may affect the procedures yield or safety. The information will be entered into a registry or data storage.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 220 participants |
| Start Date | 2011-07 |
| Est. Completion | 2012-12 |
Why NCT01397292 stopped before completion
NCT01397292 is an observational study that tracks outcomes without assigning an intervention. The registered 220 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01397292 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01397292 about?
NCT01397292 is a clinical study titled "Registry for Patients Undergoing Pulmonary Procedures". The purpose of this research study is to examine the safety, tolerability, and effectiveness of currently available pulmonary procedures when used to diagnose or treat different diseases. This study will collect information that may influence the outcome of the procedure and identify factors that m...
What is the current status of trial NCT01397292?
This trial is currently terminated. The enrollment target is 220 participants. The study started on 2011-07. Estimated completion is 2012-12.
Who is sponsoring clinical trial NCT01397292?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00920972 · 220 participants · Phase 1
Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases
- NCT01851642 · 220 participants
Lung Disease and Its Affect on the Work of White Blood Cells in the Lungs
- NCT02582021 · 220 participants
WISE CVD - Continuation (WISE HFpEF)
- NCT04067830 · 220 participants · Phase 2
Respiratory Muscle Training Before Surgery in Preventing Lung Complications in Patients With Stage I-IIIB Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia